重编程工程化自体 T 细胞以克服 Merkel 细胞癌患者的耐药性
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
利用 TCR-T 细胞疗法的力量：癌症免疫治疗的新时代
英文原题：Harnessing the power of TCR-T cell therapy: A new era in cancer immunotherapy.
查看英文原题
Harnessing the power of TCR-T cell therapy: A new era in cancer immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- Cai Y、Zhao G、Ma P、Fang H、Dong X、Wang Y、Ding J、Wang S
- 第一作者单位
- Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.China
- 通讯作者单位
- Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: lining@cicams.ac.cn.China
- 期刊
- Cancer letters2025 Mar 31
- 原文标识
- PubMed 39892699 · DOI 10.1016/j.canlet.2025.217507